Prevalence and predictive value of overweight in an urban HIV care clinic

被引:50
作者
Shuter, J
Chang, CJ
Klein, RS
机构
[1] Montefiore Med Ctr, AIDS Ctr, Dept Med, Div Infect Dis, Bronx, NY 10467 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA
[3] Montefiore Med Ctr, Dept Epidemiol & Social Med, Bronx, NY 10467 USA
关键词
HIV; overweight; prognosis;
D O I
10.1097/00126334-200103010-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To determine the prevalence and predictive value of overweight in an urban HIV clinic. Methods: Medical records of all new adult, nonpregnant registrants in 1996 in an urban HIV clinic with at least one height and weight measurement were reviewed. Body mass index (BMI) at clinic enrollment was calculated, and prevalence of overweight was thus determined. The subsequent clinical course of the overweight group was compared with that of a randomly selected group of gender-stratified non-overweight patients. Results: At baseline, 12.6% of men and 32.5% of women were overweight. Female gender and lack of AIDS diagnosis were independently associated with overweight. More than one half of women and 19.6% of men were overweight at some point during the study. Providers were more likely to properly acknowledge underweight than overweight. Among patients without AIDS, there was a trend toward slower disease progression and lower viral load in overweight patients, despite similar baseline CD4(+) lymphocyte counts and similar time to initiation of highly active antiretroviral therapy. In multivariate proportional hazards analyses, lower baseline BMI and falling BMI during follow-up were independently predictive of progression to AIDS. Conclusions: Overweight was a common and underrecognized finding, particularly among women. Overweight patients may progress more slowly to AIDS than non-overweight patients.
引用
收藏
页码:291 / 297
页数:7
相关论文
共 28 条
[1]   Disposition of zidovudine in obese pregnant women with human immunodeficiency virus type 1 infection [J].
Acosta, EP ;
Schwebke, K ;
Henry, K ;
Fletcher, CV .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (03) :673-673
[2]  
[Anonymous], 1992, MMWR Recomm Rep, V41, P1
[4]   Global issues in pediatric nutrition: AIDS [J].
Ball, CS .
NUTRITION, 1998, 14 (10) :767-770
[5]  
*CDC, 1997, MMWR-MORBID MORTAL W, V46, P199
[6]  
Centers for Disease Control (CDC), 1983, MMWR Morb Mortal Wkly Rep, V32, P101
[7]   Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers [J].
Cheymol, G ;
Poirier, JM ;
Carrupt, PA ;
Testa, B ;
Weissenburger, J ;
Levron, JC ;
Snoeck, E .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 43 (06) :563-570
[8]  
FLEGAL KM, 1988, AM J CLIN NUTR, V48, P535, DOI 10.1093/ajcn/48.3.535
[9]   In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents [J].
Glynn, SL ;
Yazdanian, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (03) :306-310
[10]   Studies of body composition and fat distribution in HIV-infected and control subjects [J].
Kotler, DP ;
Rosenbaum, K ;
Wang, J ;
Pierson, RN .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1999, 20 (03) :228-237